Oncotarget

Vol 9, No 77

October 2, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 77 of Oncotarget features Figure 2, "In mouse PCTs, deletion of hs3b-4 does not affect the pattern of chromosomal translocations but significantly increases targeting of Sμ for T(12;15)," by Kovalchuk, et al.

Table of Contents

News

An HTS FP assay able to selectively identify STAT3-DBD inhibitors

An HTS FP assay able to selectively identify STAT3-DBD inhibitors

https://doi.org/10.18632/oncotarget.26155

Fiorella Meneghetti,  and Daniela Barlocco
34451-34452
PDF  |  Order a Reprint

Can drug repurposing stop “chase and run” between aldehydes and reactive sulfur species in anti-cancer therapy?

Can drug repurposing stop “chase and run” between aldehydes and reactive sulfur species in anti-cancer therapy?

https://doi.org/10.18632/oncotarget.26170

Makoto Suematsu
34453-34454
PDF  |  Order a Reprint

Unfolding the roles of resveratrol in p53 regulation

Unfolding the roles of resveratrol in p53 regulation

https://doi.org/10.18632/oncotarget.26185

Rafaela Muniz de Queiroz,  and Carol Prives
34455-34456
PDF  |  Order a Reprint

Editorial

A new B-Raf inhibitor combo for advanced melanoma

A new B-Raf inhibitor combo for advanced melanoma

https://doi.org/10.18632/oncotarget.26171

Marjam-Jeanette Barysch, Joanna Mangana,  and Reinhard Dummer
34457-34458
PDF  |  Order a Reprint

Research Papers

Characterization of murine CEACAM1 in vivo reveals low expression on CD8+ T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1

Characterization of murine CEACAM1 in vivo reveals low expression on CD8+ T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1

https://doi.org/10.18632/oncotarget.26108

Robbie L. McLeod, Minilik H. Angagaw, Toya Nath Baral, Liming Liu, Raymond Joseph Moniz, Jason Laskey, SuChun Hsieh, Mike Lee, Jin-Hwan Han, Hassan Issafras, Sarah Javaid, Andrey Loboda, Svetlana Sadekova, Joann A. O'Connor, Archie Tse,  and Juha Punnonen
34459-34470
Abstract  |  PDF  |  HTML  |  Order a Reprint

The double stranded RNA analog poly-IC elicits both robust IFN-λ production and oncolytic activity in human gastrointestinal cancer cells

The double stranded RNA analog poly-IC elicits both robust IFN-λ production and oncolytic activity in human gastrointestinal cancer cells

https://doi.org/10.18632/oncotarget.26121

Chantal Bou-Hanna, Anne Jarry, Jean-François Mosnier, Céline Bossard,  and Christian L. Laboisse
34471-34484
Abstract  |  PDF  |  HTML  |  Order a Reprint

Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study

Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study

https://doi.org/10.18632/oncotarget.26128

Céline Lavalette, Brigitte Trétarre, Xavier Rebillard, Pierre-Jean Lamy, Sylvie Cénée,  and Florence Menegaux
34485-34494
Abstract  |  PDF  |  HTML  |  Order a Reprint

Transglutaminase is a mesothelioma cancer stem cell survival protein that is required for tumor formation

Transglutaminase is a mesothelioma cancer stem cell survival protein that is required for tumor formation

https://doi.org/10.18632/oncotarget.26130

Gautam Adhikary, Daniel Grun, H. Richard Alexander, Joseph S. Friedberg, Wen Xu, Jeffrey W. Keillor, Sivaveera Kandasamy,  and Richard L. Eckert
34495-34505
Abstract  |  PDF  |  HTML  |  Order a Reprint

Characteristic analysis of TCR β-chain CDR3 repertoire for pre-and post-liver transplantation

Characteristic analysis of TCR β-chain CDR3 repertoire for pre-and post-liver transplantation

https://doi.org/10.18632/oncotarget.26138

Guiqi Yang, Minglin Ou, Huaizhou Chen, Changchun Guo, Jiejing Chen, Hua Lin, Donge Tang, Wen Xue, Wenlong Li, Weiguo Sui,  and Yong Dai
34506-34519
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: a multicenter retrospective study

Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: a multicenter retrospective study

https://doi.org/10.18632/oncotarget.26145

Takatsugu Ogata, Hironaga Satake, Misato Ogata, Yukimasa Hatachi, Kentaro Inoue, Madoka Hamada,  and Hisateru Yasui
34520-34527
Abstract  |  PDF  |  HTML  |  Order a Reprint

3’Igh enhancers hs3b/hs4 are dispensable for Myc deregulation in mouse plasmacytomas with T(12;15) translocations

3’Igh enhancers hs3b/hs4 are dispensable for Myc deregulation in mouse plasmacytomas with T(12;15) translocations

https://doi.org/10.18632/oncotarget.26160

Alexander L. Kovalchuk, Tomomi Sakai, Chen-Feng Qi, Wendy Du Bois, Wesley A. Dunnick, Michel Cogné,  and Herbert C. Morse III
34528-34542
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Genetically coating oncolytic herpes simplex virus with CD47 allows efficient systemic delivery and prolongs virus persistence at tumor site

Genetically coating oncolytic herpes simplex virus with CD47 allows efficient systemic delivery and prolongs virus persistence at tumor site

https://doi.org/10.18632/oncotarget.26167

Xinping Fu, Lihua Tao,  and Xiaoliu Zhang
34543-34553
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Mutant TP53 modulates metastasis of triple negative breast cancer through adenosine A2b receptor signaling

Mutant TP53 modulates metastasis of triple negative breast cancer through adenosine A2b receptor signaling

https://doi.org/10.18632/oncotarget.26177

Eisuke Horigome, Michiru Fujieda, Tadashi Handa, Ayaka Katayama, Masashi Ito, Ami Ichihara, Daiki Tanaka, Navchaa Gombodorj, Shinji Yoshiyama, Arito Yamane, Keiichi Yamada, Jun Horiguchi, Kazuo Shinozuka, Tetsunari Oyama, Masahiko Nishiyama,  and Susumu Rokudai
34554-34566
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies

XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies

https://doi.org/10.18632/oncotarget.26179

Han Bit Baek, Alan P. Lombard, Stephen J. Libertini, Aleida Fernandez-Rubio, Ruth Vinall, Regina Gandour-Edwards, Rachel Nakagawa, Kathleen Vidallo, Kristine Nishida, Salma Siddiqui, Hiromi Wettersten, Yosef Landesman, Robert H. Weiss, Paramita M. Ghosh,  and Maria Mudryj
34567-34581
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma

Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma

https://doi.org/10.18632/oncotarget.26180

Utkarsh Painuly, Vijay Ramakrishnan, Teresa Kimlinger, Linda Wellik, Jessica Haug, Wilson Gonsalves, Lintao Bi, Zhongxia Huang, S. Vincent Rajkumar,  and Shaji Kumar
34582-34594
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Up-regulation of heme oxygenase-1 expression and inhibition of disease-associated features by cannabidiol in vascular smooth muscle cells

Up-regulation of heme oxygenase-1 expression and inhibition of disease-associated features by cannabidiol in vascular smooth muscle cells

https://doi.org/10.18632/oncotarget.26191

Margit Schwartz, Sabine Böckmann,  and Burkhard Hinz
34595-34616
Abstract  |  PDF  |  HTML  |  Order a Reprint

Meta-Analysis

Surrogate endpoints in advanced sarcoma trials: a meta-analysis

Surrogate endpoints in advanced sarcoma trials: a meta-analysis

https://doi.org/10.18632/oncotarget.26166

Marion Savina, Saskia Litière, Antoine Italiano, Tomasz Burzykowski, Franck Bonnetain, Sophie Gourgou, Virginie Rondeau, Jean-Yves Blay, Sophie Cousin, Florence Duffaud, Hans Gelderblom, Alessandro Gronchi, Ian Judson, Axel Le Cesne, Paul Lorigan, Joan Maurel, Winette van der Graaf, Jaap Verweij, Simone Mathoulin-Pélissier,  and Carine Bellera
34617-34627
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Reviews

The clinical relevance of progestogens in hormonal contraception: Present status and future developments

The clinical relevance of progestogens in hormonal contraception: Present status and future developments

https://doi.org/10.18632/oncotarget.26015

Pedro-Antonio Regidor
34628-34638
Abstract  |  PDF  |  HTML  |  Order a Reprint

Corrections

Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

https://doi.org/10.18632/oncotarget.26213

Marina Cazzaniga, Claudio Verusio, Mariangela Ciccarese, Alberto Fumagalli, Donata Sartori, Maria Rosaria Valerio, Mario Airoldi, Gabriella Moretti, Corrado Ficorella, Valentina Arcangeli, Lucrezia Diodati, Alberto Zambelli, Antonio Febbraro, Daniele Generali, Mirco Pistelli, Ornella Garrone, Antonino Musolino, Patrizia Vici, Michela Maur, Lucia Mentuccia, Nicla La Verde, Giulia Bianchi, Salvatore Artale, Livio Blasi, Matilde Piezzo, Francesco Atzori, Anna Turletti, Chiara Benedetto, Maria Concetta Cursano, Alessandra Fabi, Vittorio Gebbia, Alessio Schirone, Raffaella Palumbo, Antonella Ferzi, Antonio Frassoldati, Claudio Scavelli, Luca Clivio,  and Valter Torri on behalf of The EVA Study Group
34639-34640
Correction  |  PDF

Correction: Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET

Correction: Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET

https://doi.org/10.18632/oncotarget.26214

Ido D. Weiss, Lyn M. Huff, Moses O. Evbuomwan, Xin Xu, Hong Duc Dang, Daniel S. Velez, Satya P. Singh, Hongwei H. Zhang, Paul J. Gardina, Jae-Ho Lee, Liza Lindenberg, Timothy G. Myers, Chang H. Paik, David S. Schrump, Stefania Pittaluga, Peter L. Choyke, Tito Fojo,  and Joshua M. Farber
34641-34641
Correction  |  PDF


Copyright © 2018 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC